SCHEMBL24737151

SCHEMBL24737151

CC1=CN([C@H]2O[C@@H](CO)C(O)C2F)C(O)NC1=O

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CDA P32320 6/20 0.51
▸ SLC28A1 O00337 1/20 0.37
▸ SLC28A2 O43868 1/20 0.37
▸ SLC29A1 Q99808 1/20 0.37
▸ SLC28A3 Q9HAS3 1/20 0.37
▸ OGA O60502 1/20 0.36
▸ HEXB P07686 1/20 0.36
▸ PDE2A O00408 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ PYGM P11217 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22460368 1.00 CDA (0.51) CDASLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL22992439 0.88 CDA (0.45) CDASLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL21351099 0.85 CDA (0.38) CDASLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL21414072 0.74 TK1 (0.44) ADRA1A
SCHEMBL25514132 0.74 TK1 (0.44) ADRA1A
SCHEMBL18537400 0.73 ADORA2A (0.38) CDAADORA3ADORA2AADORA1
SCHEMBL13895181 0.73 CDA (0.55) CDAOGAHEXBPDE2AADORA3
SCHEMBL10024110 0.72 CDA (0.46) CDASLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL13828301 0.72 CDA (0.59) CDAMAPT
SCHEMBL10070124 0.72 CDA (0.59) CDAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256490-A9 IMPROVED SYNTHESIS OF PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS Antios Therapeutics, Inc. (US) 2023-08-17 — — WO disclosed
WO-2022256490-A2 IMPROVED SYNTHESIS OF PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS Antios Therapeutics, Inc. (US) 2022-12-08 — — WO disclosed
Send feedback